Posted on 12/3/18
Enclara Pharmacia and WellSky Announce Preferred Partnership
PHILADELPHIA--(BUSINESS WIRE)--Enclara Pharmacia (Enclara), the market leader in comprehensive pharmacy benefits management (PBM) services for the hospice community, announces a preferred partnership with WellSky, a leading . . .
Posted on 12/3/18
Tabula Rasa HealthCare To Acquire DoseMe
Tabula Rasa HealthCare, Inc. (NASDAQ: TRHC), a healthcare technology company advancing the field of medication safety, today announced it has executed a definitive agreement
Posted on 12/3/18
SRL Group Accelerates Word-of-Mouth Referrals for Physicians
NEWARK, N.J.--(BUSINESS WIRE)--Word-of-mouth referrals are the most powerful source of new patients for healthcare providers. Yet 75% of patients who receive a physician referral will search . . .
Posted on 12/3/18
Aclaris Therapeutics Closes Acquisition of RHOFADE From Allergan
WAYNE, Pa., Dec. 03, 2018 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a dermatologist-led biopharmaceutical company focused on identifying, developing, and commercializing innovative therapies to . . .
Posted on 11/30/18
Why Quest Diagnostics Stock Is Sinking Today
What happenedShares of Quest Diagnostics (NYSE:DGX) sank 9.3% as of 11:54 a.m. EST on Thursday. The diagnostics services provider gave updated full-year 2018 guidance after the . . .
Posted on 11/30/18
Is It Time to Buy Celgene?
A series of setbacks have taken a toll on Celgene's ( NASDAQ:CELG) share price, but new drugs in development may put the drugmaker back on track . . .
Posted on 11/29/18
Seavest & Trammell Crow Company Begin Development of Neighborhood Hospital for Allegheny Health Network
The firms are helping to bring expanded emergency services, cancer care and other medical services to Westmoreland County, PA. Patients of Allegheny Health Network (AHN), a . . .
Posted on 11/29/18
Realm Therapeutics Provides Update on Strategic Review
Realm Therapeutics plc (NASDAQ: RLM / AIM: RLM), a biopharmaceutical company with a proprietary technology platform of stabilized high concentration hypochlorous acid (HOCl), today provides an . . .
Posted on 11/29/18
Nevakar Completes $30 Million Financing to Advance Pipeline Products
BRIDGEWATER, N.J., Nov. 29, 2018 (GLOBE NEWSWIRE) -- Nevakar Inc., a specialty pharmaceutical company developing multiple differentiated products in the ophthalmic and injectable areas, announced today . . .
Posted on 11/29/18
Better Buy: Rite Aid vs. Walgreens Boots Alliance
It seems there's a neighborhood pharmacy on every street corner of the neighborhood. An investor could get dizzied when deciding which modernized convenience store chain, if . . .
Posted on 11/29/18
Pfizer Inc. (PFE) Management Presents on Evercore ISI HealthCONx Conference Call Transcript
Pfizer Inc. (NYSE:PFE) Evercore ISI HealthCONx Conference Call November 29, 2018 8:45 AM ET Executives Chuck Triano - SVP IR Chris Boshoff - SVP & Head . . .
Posted on 11/29/18
The Black Swan That Could Sink Celgene
You've probably heard about "black swan" events. The concept was popularized by Nassim Nicholas Taleb's best-selling book, The Black Swan. Taleb defined a black swan as . . .
Posted on 11/28/18
Alliqua BioMedical To Spin Off and Merge Its Contract Manufacturing Business with TO Pharmaceuticals
Alliqua BioMedical, Inc. (Nasdaq: ALQA) and TO Pharmaceuticals LLC, a privately held cannabinoid-based pharmaceutical therapy company
Posted on 11/28/18
Pfizer Receives FDA Approval For AML Drug
Summary Pfizer announced that it had received FDA approval for DAURISMO to treat newly diagnosed elderly patients with acute myeloid leukemia. The FDA approved DAURISMO along . . .
Posted on 11/27/18
Autonomous Healthcare Awarded Competitive Grant from the National Science Foundation
Autonomous Healthcare, Inc. has been awarded a National Science Foundation (NSF) Small Business Innovation Research (SBIR) Phase II grant for $746,668 to commercialize a clinical decision . . .
Posted on 11/27/18
AMETEK Acquires Spectro Scientific
AMETEK, Inc. (NYSE: AME) today announced that it has completed the acquisition of Spectro Scientific, a leading provider of machine condition monitoring solutions
Posted on 11/27/18
Discovery Behavioral Health Acquires Ambrosia Treatment Center
Discovery Behavioral Health, a nationwide leader in mental health services, has acquired Ambrosia Treatment Center of Medford, N.J., a facility providing evidence-based adult treatment for drug . . .
Posted on 11/27/18
Greenphire Named to Deloitte's 2018 Technology Fast 500 for Fifth Consecutive Year
Greenphire, the global leader in financial technology for clinical trials, announced today that it has been ranked as 391 on Deloitte's 2018 Technology Fast 500. This . . .
Posted on 11/27/18
Quest Diagnostics to Acquire the Laboratory Services Business of Boyce and Bynum Pathology Laboratories
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it has signed a definitive agreement to acquire the assets of . . .
Posted on 11/27/18
Calvert Labs Signs On As LabCentral Gold Sponsor
SCOTT TOWNSHIP, Pa. & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Calvert Laboratories, Inc., a non-clinical CRO, and LabCentral, Greater Boston’s premier coworking laboratory launchpad for high-potential life-science startups, today announced . . .
Posted on 11/26/18
Recovery Centers of America Opens Medication-Assisted Treatment Clinic in Trenton
Eight people die by overdose every day in New Jersey, (14 per day in PA) and these deaths are projected to worsen in the next year. . . .
Posted on 11/26/18
Bristol-Myers Squibb Awards “Golden Tickets” for LabCentral to ReviveMed, Strand Therapeutics
PRINCETON, N.J. & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE: BMY) and LabCentral, an innovative, shared laboratory space designed as a launchpad for life-sciences and biotech startups, . . .
Posted on 11/26/18
Better Buy: Pfizer vs. Bristol-Myers Squibb
Frenemies might be one of those annoying word mash-ups, but the term definitely describes the relationship between two of the biggest drugmakers on the planet: Pfizer . . .
Posted on 11/21/18
Celgene's Positives Greatly Outweigh Negatives
Summary Celgene had some bad news, driving the stock to bargain prices in 2018. Ozanimod and Fedratinib applications to the FDA will be good signs. Multiple . . .
Posted on 11/21/18
Aquestive Provides Business Update Following Suboxone Patent Ruling
Aquestive Therapeutics today received news that The U.S. Court of Appeals for the Federal Circuit overturned the preliminary injunction against Dr. Reddy's Laboratories ("DRL") as it . . .

